Montosa-I-Micó Víctor, Álvarez-Torres María Del Mar, Burgos-Panadero Rebeca, Gil-Terrón F Javier, Gómez Mahiques Maria, Lopez-Mateu Carles, García-Gómez Juan M, Fuster-Garcia Elies
Instituto Universitario de Tecnologías de la Información y Comunicaciones (ITACA), BDSLab, Universitat Politècnica de València, Spain.
Laboratory of Cellular and Molecular Biology, Clinical and Translational Research in Cancer Group, La Fe Health Research Institute, Valencia, Spain.
Heliyon. 2024 May 17;10(11):e31175. doi: 10.1016/j.heliyon.2024.e31175. eCollection 2024 Jun 15.
The vascular heterogeneity of glioblastomas (GB) remains an important area of research, since tumor progression and patient prognosis are closely tied to this feature. With this study, we aim to identify gene expression profiles associated with MRI-defined tumor vascularity and to investigate its relationship with patient prognosis.
The study employed MRI parameters calculated with DSC Perfusion Quantification of ONCOhabitats glioma analysis software and RNA-seq data from the TCGA-GBM project dataset. In our study, we had a total of 147 RNA-seq samples, which 15 of them also had MRI parameter information. We analyzed the gene expression profiles associated with MRI-defined tumor vascularity using differential gene expression analysis and performed Log-rank tests to assess the correlation between the identified genes and patient prognosis.
The findings of our research reveal a set of 21 overexpressed genes associated with the high vascularity pattern. Notably, several of these overexpressed genes have been previously implicated in worse prognosis based on existing literature. Our log-rank test further validates that the collective upregulation of these genes is indeed correlated with an unfavorable prognosis. This set of genes includes a variety of molecules, such as cytokines, receptors, ligands, and other molecules with diverse functions.
Our findings suggest that the set of 21 overexpressed genes in the High Vascularity group could potentially serve as prognostic markers for GB patients. These results highlight the importance of further investigating the relationship between the molecules such as cytokines or receptors underlying the vascularity in GB and its observation through MRI and developing targeted therapies for this aggressive disease.
胶质母细胞瘤(GB)的血管异质性仍是一个重要的研究领域,因为肿瘤进展和患者预后与这一特征密切相关。通过本研究,我们旨在识别与MRI定义的肿瘤血管相关的基因表达谱,并研究其与患者预后的关系。
本研究采用ONCOhabitats胶质瘤分析软件的DSC灌注定量计算的MRI参数以及来自TCGA-GBM项目数据集的RNA测序数据。在我们的研究中,共有147个RNA测序样本,其中15个样本也有MRI参数信息。我们使用差异基因表达分析来分析与MRI定义的肿瘤血管相关的基因表达谱,并进行对数秩检验以评估所识别基因与患者预后之间的相关性。
我们的研究结果揭示了一组与高血管模式相关的21个过表达基因。值得注意的是,根据现有文献,这些过表达基因中的几个先前已被认为与较差的预后有关。我们的对数秩检验进一步证实,这些基因的集体上调确实与不良预后相关。这组基因包括多种分子,如细胞因子、受体、配体和其他具有不同功能的分子。
我们的研究结果表明,高血管组中的21个过表达基因可能作为GB患者的预后标志物。这些结果凸显了进一步研究GB血管形成背后的细胞因子或受体等分子之间的关系以及通过MRI观察这种关系,并为这种侵袭性疾病开发靶向治疗的重要性。